These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38561692)

  • 21. Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
    Abdelhak A; Hottenrott T; Morenas-Rodríguez E; Suárez-Calvet M; Zettl UK; Haass C; Meuth SG; Rauer S; Otto M; Tumani H; Huss A
    Front Neurol; 2019; 10():280. PubMed ID: 30972011
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
    McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
    JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia.
    Chatziefstathiou A; Canaslan S; Kanata E; Vekrellis K; Constantinides VC; Paraskevas GP; Kapaki E; Schmitz M; Zerr I; Xanthopoulos K; Sklaviadis T; Dafou D
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
    J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
    Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
    Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers.
    Murueta-Goyena A; Cipriani R; Carmona-Abellán M; Acera M; Ayo N; Del Pino R; Tijero B; Fernández-Valle T; Gabilondo I; Zallo F; Matute C; Sánchez-Pernaute R; Khurana V; Cavaliere F; Capetillo-Zarate E; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2022 Mar; 96():29-35. PubMed ID: 35149357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
    J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia.
    Silva-Spínola A; Lima M; Leitão MJ; Bernardes C; Durães J; Duro D; Tábuas-Pereira M; Santana I; Baldeiras I
    Eur J Neurol; 2023 Jun; 30(6):1565-1573. PubMed ID: 36880887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Biostatistical Models to Manage Replicate Error in Concussion Biomarker Research.
    Tabor JB; Galarneau JM; Penner LC; Cooper J; Ghodsi M; Fraser DD; Wellington CL; Debert CT; Emery CA
    JAMA Netw Open; 2023 Oct; 6(10):e2339733. PubMed ID: 37870831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    Li TR; Lyu DY; Liu FQ;
    J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamics of Selected Biomarkers in Cerebrospinal Fluid During Complex Endovascular Aortic Repair - A Pilot Study.
    Jónsson GG; Marklund N; Blennow K; Zetterberg H; Wanhainen A; Lindström D; Eriksson J; Mani K
    Ann Vasc Surg; 2022 Jan; 78():141-151. PubMed ID: 34175417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
    Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
    Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache.
    de Boni L; Odainic A; Gancarczyk N; Kaluza L; Strassburg CP; Kersting XAK; Wüllner U; Schmidt SV; Petzold GC
    Neurol Res Pract; 2023 Sep; 5(1):49. PubMed ID: 37759276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Player Position on Serum Biomarkers during Participation in a Season of Collegiate Football.
    Papa L; Walter AE; Wilkes JR; Clonts HS; Johnson B; Slobounov SM
    J Neurotrauma; 2022 Oct; 39(19-20):1339-1348. PubMed ID: 35615873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.